PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.\', \'Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.\', \'Infectious and Tropical Diseases Research Center, Tabriz University of Medical Science, P.O. Box: 5163639888, Tabriz, Iran. le.rahbarnia@gmail.com.\', \'Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, P.O. Box: 5165665811, Tabriz, Iran. azamsafary@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s15010-021-01730-6
?:hasPublicationType
?:journal
  • Infection
is ?:pmid of
?:pmid
?:pmid
  • 34902115
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.171
?:rankingScore_hIndex
  • 64
is ?:relation_isRelatedTo_publication of
?:title
  • Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34902115>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34902115>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all